Phase I clinical trial of peptide vaccine with UFT/LV for advanced or recurrent colorectal cancer

ABSTRACT: Interventions: Peptide vaccine therapy Primary outcome(s): We confirm the safety of the peptide vaccine against colorectal cancer patient. Study Design: Single arm Non-randomized

DISEASE(S): Advanced Or Recurrent Colorectal Cancer

PROVIDER: 2619902 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR